US Stock MarketDetailed Quotes
BLPH Bellerophon Therapeutics
- 0.059
- +0.008+14.68%
15min DelayClose Apr 23 16:00 ET
716.83KMarket Cap-65P/E (TTM)
0.059High0.059Low5.01KVolume0.059Open0.051Pre Close293.70Turnover0.04%Turnover RatioLossP/E (Static)12.23MShares11.15052wk High0.19P/B697.73KFloat Cap0.02952wk Low--Dividend TTM11.91MShs Float193.800Historical High--Div YieldTTM0.00%Amplitude0.029Historical Low0.058Avg Price1Lot Size
About Bellerophon Therapeutics Company
Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.
Company Profile
SymbolBLPH
Company NameBellerophon Therapeutics
Listing DateFeb 13, 2015
Issue Price12.00
Founded2009
CEOMr. Peter Fernandes
MarketPink Market
Employees18
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address184 Liberty Corner Road,Suite 302
CityWarren
ProvinceNew Jersey
CountryUnited States of America
Zip Code07059
Phone1-908-574-4770
Websitehttp://www.bellerophon.com
Company Executives
- Name
- Position
- Salary
- Bobae Kim
- Vice President, Regulatory Affairs and Quality Assurance
- --
- Naseem Amin
- Chairman of the Board
- 83.10K
- Scott P. Bruder
- Independent Director
- 84.90K
- Mary Ann Cloyd
- Independent Director
- 97.40K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg